GlassScriptPhysician profile
Ronald C Lee
NPI 1053528497
$517.68
in general payments reported to CMS, 2019-2025
11 companies · $15.92 in 2025
The $15.92 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $31.90 · 2021: $121 · 2022: $16.12 · 2023: $73.08 · 2024: $24.96 · 2025: $15.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $113.49 | 2021-2022 | |
| Amgen INC. | $95.29 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.74 | 2019-2020 | |
| Cook Medical LLC | $63.41 | 2021-2023 | Advance |
| Medtronic, INC. | $45.98 | 2023-2024 | Nexpowder, Eleview |
| Pfizer INC. | $41.60 | 2019-2021 | |
| Shire North American Group INC | $24.23 | 2019 | |
| Ucb, INC. | $19.09 | 2019 | |
| Abbvie INC. | $16.06 | 2019 | |
| Janssen Biotech, INC. | $15.92 | 2025 | Tremfya |
| Merck Sharp & Dohme LLC | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.